Jeffrey A. Meckler
Net Worth
Last updated:
What is Jeffrey A. Meckler net worth?
The estimated net worth of Mr. Jeffrey A. Meckler is at least $3,748,740 as of 21 Nov 2022. He owns shares worth $556,260 as insider and has received compensation worth at least $3,192,480 in Indaptus Therapeutics, Inc..
What is the salary of Jeffrey A. Meckler?
Mr. Jeffrey A. Meckler salary is $798,120 per year as Chief Executive Officer & Director in Indaptus Therapeutics, Inc..
How old is Jeffrey A. Meckler?
Mr. Jeffrey A. Meckler is 58 years old, born in 1967.
What stocks does Jeffrey A. Meckler currently own?
As insider, Mr. Jeffrey A. Meckler owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | Chief Executive Officer & Director | 75,374 | $7.38 | $556,260 |
What does Indaptus Therapeutics, Inc. do?
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Jeffrey A. Meckler insider trading
Indaptus Therapeutics, Inc.
Indaptus Therapeutics key executives
Indaptus Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Michael J. Newman Ph.D. (69) Founder, Chief Scientific Officer & Director
- Mr. Jeffrey A. Meckler (58) Chief Executive Officer & Director
- Mr. Nir Sassi (49) Chief Financial Officer
- Mr. Walt Addison Linscott Esq. (64) Chief Bus. Officer